| Literature DB >> 21599030 |
Dipanjan Pan1, Shelton D Caruthers, Angana Senpan, Ceren Yalaz, Allen J Stacy, Grace Hu, Jon N Marsh, Patrick J Gaffney, Samuel A Wickline, Gregory M Lanza.
Abstract
A new site-targeted molecular imaging contrast agent based on a nanocolloidal suspension of lipid-encapsulated, organically soluble divalent copper has been developed. Concentrating a high payload of divalent copper ions per nanoparticle, this agent provides a high per-particle r1 relaxivity, allowing sensitive detection in T1-weighted magnetic resonance imaging when targeted to fibrin clots in vitro. The particle also exhibits a defined clearance and safety profile in vivo.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21599030 PMCID: PMC3124378 DOI: 10.1021/ja201918u
Source DB: PubMed Journal: J Am Chem Soc ISSN: 0002-7863 Impact factor: 15.419